Insider Trading Signals — September 30, 2026 — Midday Update — Last 24 Hours (Pacific Time)

Executive Summary

The past 24 hours were dominated by insider selling, with C-suite executives at multiple companies — including Arista Networks, StoneX Group, Definium Therapeutics, and Marriott International — offloading significant positions. The most notable bullish signal comes from H.B. Fuller, where five directors made coordinated purchases totaling roughly $499K, representing one of the strongest cluster-buy signals in this period. Pale Fire Capital's $11.3M purchase of Coursera stock and Nippon Life Insurance's $6.17M buy of Corebridge Financial stand out as the largest individual buy transactions.

Activity Breakdown

Net Signal: 🔴 Bearish — Net selling of approximately $9.9M over the period.

Note: Totals are aggregated from reported headline figures. Some transactions list approximate values.

Top Notable Transactions

🟢 Coursera (COUR) — Strong Bullish

• Insider: Pale Fire Capital SE, 10% Owner & Director
• Transaction: Purchase of $11.3M
• Signal: Strong Bullish
• Context: A 10% owner and director adding $11.3M in shares is a high-conviction bet on Coursera's trajectory — this is the largest single purchase in the period.

🟢 Corebridge Financial (CRBG) — Moderate Bullish

• Insider: Nippon Life Insurance Co., 10% Owner & Director
• Transaction: Purchase of $6.17M (178,840 shares)
• Signal: Moderate Bullish
• Context: A major institutional insider adding over $6M signals continued confidence in Corebridge's long-term value.

🟢 H.B. Fuller (FUL) — Strong Bullish (Cluster)

• Insiders: Daniel L. Florness ($100,160), Charles Lauber ($99,984), Thomas Handley ($98,820), Teresa J. Rasmussen Trangsrud ($99,984), Srilata Zaheer ($100,118) — all Directors
• Transaction: Combined purchases of ~$499K
• Signal: Strong Bullish
• Context: Five directors buying simultaneously in near-identical amounts is a textbook cluster-buy signal, suggesting the board collectively views the stock as undervalued.

🔴 Arista Networks (ANET) — Moderate Bearish

• Insider: Jayshree Ullal, CEO & Chairperson
• Transaction: Sale of $13.2M (62,622 shares from trusts)
• Signal: Moderate Bearish
• Context: The CEO offloading $13.2M — even from trusts — is the largest single sale of the period and warrants attention, though trust-based sales are often pre-planned.

🔴 StoneX Group (SNEX) — Moderate Bearish

• Insider: Philip Andrew Smith, CEO & Director
• Transaction: Sale of $3.7M
• Signal: Moderate Bearish
• Context: A CEO selling $3.7M in a series of transactions is a meaningful signal, particularly given the size relative to the company.

🔴 Definium Therapeutics (DFTX) — Strong Bearish (Cluster)

• Insiders: CEO Robert Barrow ($1.15M), CLO Mark Sullivan ($513,845), CMO Daniel Karlin ($396,894), CFO Brandi Roberts ($123,496), CCO Matthew Wiley ($113,257)
• Transaction: Combined sales of ~$2.3M
• Signal: Strong Bearish
• Context: Five C-suite executives selling simultaneously is a significant red flag — broad insider distribution at this level rarely signals confidence.

🔴 Marriott International (MAR) — Moderate Bearish (Cluster)

• Insiders: Deborah Marriott Harrison ($1.23M), J W Jr Marriott ($1.23M), David S. Marriott ($1.23M) — all Directors / 10%+ owners
• Transaction: Combined sales of ~$3.69M
• Signal: Moderate Bearish
• Context: Three members of the founding Marriott family selling identical amounts simultaneously suggests coordinated distribution, though family estate planning is a common driver.

🔴 Kura Oncology (KURA) — Strong Bearish (Cluster)

• Insiders: CMO Mollie Leoni ($440,236), CCO Brian Powl ($345K+), COO Kathleen Ford ($111,930), CLO Teresa Brophy Bair ($88,618), SVP Thomas Doyle ($48,360)
• Transaction: Combined sales of ~$1.03M+
• Signal: Strong Bearish
• Context: Five executives selling across the same period is a notable cluster-sell event for this mid-cap oncology name.

🔴 First Bancorp NC (FBNC) — Moderate Bearish

• Insider: Richard H. Moore, CEO & Director
• Transaction: Sale of $1.47M
• Signal: Moderate Bearish
• Context: A CEO selling $1.47M in company stock is a meaningful signal for a regional bank.

🔴 Ciena Corp (CIEN) — Moderate Bearish

• Insider: Joseph Cumello, EVP & General Manager
• Transaction: Sale of $568,604 (1,586 shares)
• Signal: Moderate Bearish
• Context: The high per-share value implies a premium stock price; an EVP selling over half a million dollars is notable for Ciena.

🔴 Abeona Therapeutics (ABEO) — Strong Bearish (Cluster)

• Insiders: CEO Vishwas Seshadri ($101,091), CFO Joseph Vazzano ($47,385), CCO Vasanthavada Madhav ($25,272), SVP/CLO Brendan O'Malley ($34,681)
• Transaction: Combined sales of ~$208K
• Signal: Strong Bearish
• Context: Four senior executives selling in the same period is a clear cluster-sell signal for this small-cap biotech.

🔴 Arlo Technologies (ARLO) — Moderate Bearish

• Insider: Kurtis Joseph Binder, CFO
• Transaction: Sale of $1.2M (96,569 shares)
• Signal: Moderate Bearish
• Context: A CFO selling $1.2M — with the highest visibility into financials — is worth monitoring.

🔴 EOG Resources (EOG) — Moderate Bearish

• Insider: Jeffrey R. Leitzell, EVP & COO
• Transaction: Sale of $1.27M (9,039 shares)
• Signal: Moderate Bearish
• Context: A COO selling over $1M in a major energy company adds to the broader selling trend in the sector.

🟢 Zedge (ZDGE) — Moderate Bullish

• Insider: Howard S. Jonas, Director & 10% Owner
• Transaction: Acquisition of 2,218,430 Class B shares
• Signal: Moderate Bullish
• Context: A 10% owner acquiring over 2.2 million shares is a strong show of conviction, though the dollar value was not specified in the available data.

Pattern Analysis

🔴 Definium Therapeutics (DFTX) — Broad C-Suite Cluster Sell
Net Signal: Strongly Bearish | Companies: DFTX | Total Value: ~$2.3M
Five executives — CEO, CFO, CLO, CMO, and CCO — all sold shares around September 25, 2026. This level of coordinated selling across the entire leadership team is one of the most significant bearish cluster signals in this period, often associated with post-lock-up expirations or reduced internal confidence.

🔴 Kura Oncology (KURA) — Multi-Executive Cluster Sell
Net Signal: Bearish | Companies: KURA | Total Value: ~$1.03M+
Five Kura Oncology executives across commercial, medical, legal, operations, and finance sold shares in the same window. Cluster selling of this breadth in a clinical-stage oncology company warrants close attention.

🔴 Abeona Therapeutics (ABEO) — C-Suite Cluster Sell
Net Signal: Bearish | Companies: ABEO | Total Value: ~$208K
CEO, CFO, CCO, and CLO all sold within the same reporting window. While individual amounts are modest, the breadth of participation is a meaningful signal.

🟢 H.B. Fuller (FUL) — Board-Level Cluster Buy
Net Signal: Strongly Bullish | Companies: FUL | Total Value: ~$499K
Five directors purchased shares in near-identical amounts (~$99K–$100K each) across September 28–29, 2026. This coordinated board-level buying is one of the clearest bullish signals in the period — directors rarely buy in lockstep without conviction.

🔴 Marriott International (MAR) — Family Insider Cluster Sell
Net Signal: Bearish | Companies: MAR | Total Value: ~$3.69M
Three members of the Marriott family sold identical amounts (~$1.23M each) simultaneously. While family estate planning is a plausible explanation, the coordination and scale are notable.

🔴 Biotech/Pharma Sector — Broad Selling Trend
Net Signal: Bearish | Companies: ABEO, DFTX, KURA, ORIC, RVMD
Multiple biotech and pharma insiders sold shares across the period, with cluster activity at three separate companies. This sector-wide selling pattern may reflect post-catalyst profit-taking or broader sector caution.

🔴 Pagaya Technologies (PGY) — Multi-Insider Selling
Net Signal: Bearish | Companies: PGY | Total Value: ~$290K
President Sanjiv Das ($243,672), CFO Jonathan Dobres ($10,053), and CAO Cory Vieira ($36,976) all sold shares in the same period — a modest but broad signal of insider distribution.

Sector Breakdown

Technology (🔴 Bearish)

• Net Signal: ~$15.5M net selling
• Notable: Arista Networks (ANET), Samsara (IOT), Arlo Technologies (ARLO), Pagaya (PGY), Globalfoundries (GFS), Photronics (PLAB)
• Context: Heavy selling from tech executives led by Arista's CEO $13.2M sale dominates the sector.

Biotech / Pharmaceuticals (🔴 Strong Bearish)

• Net Signal: ~$3.5M+ net selling
• Notable: Definium Therapeutics (DFTX), Kura Oncology (KURA), Abeona Therapeutics (ABEO), Oric Pharmaceuticals (ORIC), Revolution Medicines (RVMD)
• Context: Broad cluster selling across multiple biotech names with no meaningful offsetting purchases makes this the most bearish sector of the period.

Education Technology (🟢 Bullish)

• Net Signal: ~$11.3M net buying
• Notable: Coursera (COUR)
• Context: Pale Fire Capital's $11.3M purchase is the dominant signal, making EdTech the most bullish sector by dollar value.

Industrials / Specialty Chemicals (🟢 Bullish)

• Net Signal: ~$499K net buying
• Notable: H.B. Fuller (FUL)
• Context: Five-director cluster buy at FUL is the strongest quality signal in the sector.

Insurance / Financial Services (🟢 Bullish)

• Net Signal: ~$6.17M net buying
• Notable: Corebridge Financial (CRBG), Aflac (AFL — selling by Japan Post)
• Context: Nippon Life's large purchase of Corebridge offsets Japan Post's Aflac sale; net bullish for the sector.

Hospitality / Consumer (🔴 Bearish)

• Net Signal: ~$3.69M net selling
• Notable: Marriott International (MAR)
• Context: Coordinated family selling at Marriott is the primary driver of sector bearishness.

Energy (🔴 Bearish)

• Net Signal: ~$1.27M net selling
• Notable: EOG Resources (EOG), Southwest Gas (SWX)
• Context: COO-level selling at EOG and SVP selling at Southwest Gas reflect modest but consistent insider distribution in energy.

Banking / Regional Finance (🔴 Bearish)

• Net Signal: ~$1.47M net selling
• Notable: First Bancorp NC (FBNC)
• Context: CEO-level selling at a regional bank is a cautionary signal for the sector.

Market Implications

The overall insider sentiment for this 24-hour window leans bearish, with selling outpacing buying by roughly $9.9M in net terms. However, the quality of buying — particularly the five-director cluster at H.B. Fuller and Pale Fire Capital's $11.3M Coursera purchase — provides meaningful counterweights. Insider purchases are generally considered higher-conviction signals than sales, since executives sell for many reasons (diversification, taxes, estate planning) but typically buy only when they believe the stock is undervalued.

The biotech and pharmaceutical sector stands out as the most concerning area, with cluster selling at three separate companies (Definium Therapeutics, Kura Oncology, and Abeona Therapeutics) in the same reporting window. When multiple C-suite executives across multiple companies in the same sector sell simultaneously, it often reflects shared awareness of sector headwinds or post-catalyst distribution. Investors with biotech exposure should take note.

On the bullish side, the EdTech and specialty chemicals spaces show genuine insider conviction. Pale Fire Capital's $11.3M Coursera purchase — from a 10% owner with board-level visibility — is the single most bullish signal of the period. H.B. Fuller's five-director coordinated buy is a textbook cluster-buy signal that historically carries strong predictive weight. These two names deserve attention from investors looking for insider-backed opportunities.

Key Takeaways

• 🟢 Coursera (COUR) — A 10% owner/director buying $11.3M is the highest-conviction bullish signal of the period; largest single purchase by far.
• 🟢 H.B. Fuller (FUL) — Five directors buying ~$100K each simultaneously is a rare, high-quality cluster-buy signal; the board appears to see clear value.
• 🟢 Corebridge Financial (CRBG) — Nippon Life's $6.17M purchase reinforces institutional insider confidence in this insurance holding company.
• 🔴 Arista Networks (ANET) — CEO Jayshree Ullal's $13.2M trust-based sale is the largest single sale; worth monitoring even if pre-planned.
• 🔴 Definium Therapeutics (DFTX) — Five C-suite executives selling ~$2.3M combined is the strongest bearish cluster signal of the period; a major red flag.
• 🔴 Kura Oncology (KURA) — Five executives selling over $1M combined signals broad insider distribution at this oncology name.
• 🔴 Marriott International (MAR) — Three Marriott family members selling ~$1.23M each simultaneously totals ~$3.69M; coordinated family selling warrants scrutiny.
• 🔴 StoneX Group (SNEX) — CEO selling $3.7M in a series of transactions is a meaningful bearish signal for this financial services firm.
• 🔴 Abeona Therapeutics (ABEO) — CEO, CFO, CCO, and CLO all selling in the same window is a broad cluster-sell signal for this small-cap biotech.
• 🔴 Biotech sector broadly — Three separate cluster-sell events across DFTX, KURA, and ABEO in 24 hours suggests sector-wide insider caution.
• 🔴 First Bancorp NC (FBNC) — CEO selling $1.47M in a regional bank is a notable bearish signal for the community banking space.
• 🟢 Zedge (ZDGE) — A 10% owner acquiring 2.2M+ Class B shares is a high-conviction accumulation signal; dollar value not fully specified.
• 🔴 Pagaya Technologies (PGY) — President, CFO, and CAO all selling in the same window (~$290K combined) signals insider distribution.
• 🔴 Overall ratio: ~38 sales vs. 14 purchases — The 2.7:1 sell-to-buy ratio by count, and ~$9.9M net selling, reflects a broadly cautious insider sentiment heading into quarter-end.
• 🟡 Quarter-end timing — Many of these transactions cluster around September 25–29, consistent with quarter-end tax planning, rebalancing, and compensation-related sales; context matters when interpreting individual transactions.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/